Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Clinical trial NCT05753501 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05753501
Sponsor: AbbVie
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Cancer

Start date: 2023-06-09
Primary completion: 2031-03-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.